Science Explorer Back to mapMap

Most cited papers in IgG4-Related and Inflammatory Diseases

IgG4-Related and Inflammatory Diseases

What are the most cited papers in IgG4-Related and Inflammatory Diseases?

The most cited paper in IgG4-Related and Inflammatory Diseases is "High Serum IgG4 Concentrations in Patients with Sclerosing Pancreatitis" (Hideaki Hamano, Shigeyuki Kawa, Akira C. Horiuchi et al., 2001), with 2,725 citations. Next come "IgG4-Related Disease" (2,629) and "Consensus statement on the pathology of IgG4-related disease" (2,616).

Showing 50 of 97 papers. Every paper with more than 462 citations is listed.

Most cited papers, sortable by citations and release date
#Paper
1 High Serum IgG4 Concentrations in Patients with Sclerosing Pancreatitis Hideaki Hamano, Shigeyuki Kawa, Akira C. Horiuchi et al. · New England Journal of Medicine Open access 8 Mar 2001 2,725
2 IgG4-Related Disease John H. Stone, Yoh Zen, Vikram Deshpande · New England Journal of Medicine 8 Feb 2012 2,629
3 Consensus statement on the pathology of IgG4-related disease Vikram Deshpande et al. · Modern Pathology Open access 18 May 2012 2,616
4 Simplified criteria for the diagnosis of autoimmune hepatitis† Elke M. Hennes, Mikio Zeniya, Albert J. Czaja et al. · Hepatology Open access 19 Mar 2008 1,907
5 A Step-up Approach or Open Necrosectomy for Necrotizing Pancreatitis Hjalmar C. van Santvoort et al. · New England Journal of Medicine Open access 21 Apr 2010 1,726
6 Comprehensive diagnostic criteria for IgG4-related disease (IgG4-RD), 2011 Hisanori Umehara et al. · Modern Rheumatology 4 Jan 2012 1,661
7 Pemigatinib for previously treated, locally advanced or metastatic cholangiocarcinoma: a multicentre, open-label, phase 2 study Ghassan K. Abou‐Alfa, Vaibhav Sahai, Antoine Hollebecque et al. · The Lancet Oncology Open access 20 Mar 2020 1,634
8 Extrapulmonary Inflammatory Myofibroblastic Tumor (Inflammatory Pseudotumor) A Clinicopathologic and Immunohistochemical Study of 84 Cases Cheryl M. Coffin, Jan Watterson, John R. Priest et al. · The American Journal of Surgical Pathology Aug 1995 1,593
9 International Consensus Diagnostic Criteria for Autoimmune Pancreatitis Tooru Shimosegawa, Suresh T. Chari, Luca Frulloni et al. · Pancreas 16 Mar 2011 1,529
10 A new clinicopathological entity of IgG4-related autoimmune disease Terumi Kamisawa, Nobuaki Funata, Yukiko K Hayashi et al. · Journal of Gastroenterology Oct 2003 1,470
11 Chronic pancreatitis caused by an autoimmune abnormality Kenji Yoshida, Fumitake Toki, Tadashi Takeuchi et al. · Digestive Diseases and Sciences Jul 1995 1,434
12 Trial of Tocilizumab in Giant-Cell Arteritis John H. Stone, Katie Tuckwell, Sophie Dimonaco et al. · New England Journal of Medicine Open access 26 Jul 2017 1,400
13 Development and validation of a consensus methodology for the classification of the ANCA-associated vasculitides and polyarteritis nodosa for epidemiological studies Richard Watts, Suzanne E. Lane, Thomas Hanslik et al. · Annals of the Rheumatic Diseases Open access 10 Aug 2006 1,375
14 IgG4-related disease Terumi Kamisawa, Yoh Zen, Shiv S Pillai et al. · The Lancet 3 Dec 2014 1,222
15 Revised Prognostic Staging System for Light Chain Amyloidosis Incorporating Cardiac Biomarkers and Serum Free Light Chain Measurements Shaji Kunnathu Kumar, Angela Dispenzieri, Martha Q. Lacy et al. · Journal of Clinical Oncology Open access 14 Feb 2012 1,143
16 International Consensus Guidance Statement on the Management and Treatment of IgG4‐Related Disease Arezou Khosroshahi et al. · Arthritis & Rheumatology 25 Mar 2015 1,071
17 Genetically Distinct Subsets within ANCA-Associated Vasculitis Paul Lyons et al. · New England Journal of Medicine Open access 19 Jul 2012 1,020
18 Guidelines for the use of immunosuppressive drugs in patients with ocular inflammatory disorders: recommendations of an expert panel Douglas A. Jabs, James Todd Rosenbaum, Charles Stephen Foster et al. · American Journal of Ophthalmology Open access Oct 2000 999
19 Hereditary Pancreatitis and the Risk of Pancreatic Cancer Albert B. Lowenfels, Patrick Maisonneuve, Eugene P. DiMagno et al. · JNCI Journal of the National Cancer Institute 19 Mar 1997 999
20 New Criteria for Response to Treatment in Immunoglobulin Light Chain Amyloidosis Based on Free Light Chain Measurement and Cardiac Biomarkers: Impact on Survival Outcomes Giovanni O. Palladini, Angela Dispenzieri, Morie Abraham Gertz et al. · Journal of Clinical Oncology 23 Oct 2012 986
21 Inflammatory Myofibroblastic Tumor Cheryl M. Coffin, Jason L. Hornick, Christopher D.�M. Fletcher · The American Journal of Surgical Pathology 23 Mar 2007 985
22 Diagnosis of Autoimmune Pancreatitis: The Mayo Clinic Experience Suresh T. Chari, Thomas C. Smyrk, Michael J. Levy et al. · Clinical Gastroenterology and Hepatology 17 Jul 2006 977
23 Eosinophilic granulomatosis with polyangiitis (Churg‐Strauss): Clinical characteristics and long‐term followup of the 383 patients enrolled in the French Vasculitis Study Group cohort Cloé Comarmond et al. · Arthritis & Rheumatism 8 Oct 2012 937
24 Natural History and Outcome in Systemic AA Amyloidosis Helen J. Lachmann, Hugh J.B. Goodman, Janet A. Gilbertson et al. · New England Journal of Medicine Open access 6 Jun 2007 899
25 Immunoglobulin G4–Associated Cholangitis: Clinical Profile and Response to Therapy Amaar H. Ghazale, Suresh T. Chari, Lizhi Zhang et al. · Gastroenterology Open access 29 Jan 2008 897
26 Efficacy and safety of adalimumab in patients with ankylosing spondylitis: Results of a multicenter, randomized, double‐blind, placebo‐controlled trial Désirée M F M van der Heijde, Alan Kivitz, Michael H. Schiff et al. · Arthritis & Rheumatism 26 Jun 2006 882
27 Crizotinib in ALK -Rearranged Inflammatory Myofibroblastic Tumor James Edward Butrynski, David R. D’Adamo, Jason L. Hornick et al. · New England Journal of Medicine Open access 27 Oct 2010 874
28 PDGFRA Mutations in Gastrointestinal Stromal Tumors: Frequency, Spectrum and In Vitro Sensitivity to Imatinib Christopher L. Corless, Arin J. Schroeder, Diana Griffith et al. · Journal of Clinical Oncology Jun 2005 854
29 Natural history and outcome in systemic AA amyloidosis Lachmann, HJ, Goodman, HJB, Gilbertson, JA et al. · UCL Discovery (University College London) 7 Jun 2007 782
30 The 2019 American College of Rheumatology/European League Against Rheumatism classification criteria for IgG4-related disease Zachary Scott Wallace, Ray Naden, Suresh T. Chari et al. · Annals of the Rheumatic Diseases 3 Dec 2019 770
31 Clinicopathologic correlates of solitary fibrous tumors Jason S. Gold, Cristina R. Antonescu, Cristina H Hajdu et al. · Cancer 15 Feb 2002 768
32 Inflammatory myofibroblastic tumours: where are we now? Briana C. Gleason, Jason L. Hornick · Journal of Clinical Pathology Open access 15 Oct 2007 760
33 International Uveitis Study Group Recommendations for the Evaluation of Intraocular Inflammatory Disease Etienne Bloch-Michel, Robert Burton Nussenblatt · American Journal of Ophthalmology Feb 1987 731
34 Recommendations for the nomenclature of IgG4‐related disease and its individual organ system manifestations John H. Stone et al. · Arthritis & Rheumatism Open access 26 Jun 2012 731
35 Guideline of transthyretin-related hereditary amyloidosis for clinicians Yukio Ando, Teresa Coelho, John L. Berk et al. · Orphanet Journal of Rare Diseases Open access 2013 729
36 Standard steroid treatment for autoimmune pancreatitis T Kamisawa, Tooru Shimosegawa, Kazuichi Okazaki et al. · Gut 26 Apr 2009 727
37 Rituximab for IgG4-related disease: a prospective, open-label trial Mollie N. Carruthers, Mark D. Topazian, Arezou Khosroshahi et al. · Annals of the Rheumatic Diseases 9 Feb 2015 726
38 TPM3-ALK and TPM4-ALK Oncogenes in Inflammatory Myofibroblastic Tumors Brandon Douglas Lawrence, Antonio R. Pérez‐Atayde, Michele K. Hibbard et al. · American Journal Of Pathology Open access Aug 2000 723
39 Phase II Study of BGJ398 in Patients With FGFR-Altered Advanced Cholangiocarcinoma Milind M. Javle et al. · Journal of Clinical Oncology Open access 28 Nov 2017 721
40 A novel clinical entity, IgG4-related disease (IgG4RD): general concept and details Hisanori Umehara et al. · Modern Rheumatology Open access 31 Aug 2011 720
41 The Role of Cytokines in the Pathogenesis of Acute Pancreatitis Jim C. Norman · The American Journal of Surgery 1998 713
42 The different courses of early- and late-onset idiopathic and alcoholic chronic pancreatitis Peter Layer, Hironori Yamamoto, Ludwig Kalthoff et al. · Gastroenterology Nov 1994 708
43 Pulmonary Sarcoidosis Gary W. Hunninghake, Ronald G. Crystal · New England Journal of Medicine 20 Aug 1981 691
44 Inflammatory mediators in human acute pancreatitis: clinical and pathophysiological implications Jens M. Mayer, B Rau, F Gansauge et al. · Gut Open access Oct 2000 670
45 IgG4‐Related Disease: Clinical and Laboratory Features in One Hundred Twenty‐Five Patients Zachary Scott Wallace, Vikram Deshpande, Hamid Mattoo et al. · Arthritis & Rheumatology Open access 18 May 2015 669
46 Histopathological features of diagnostic and clinical relevance in autoimmune pancreatitis: a study on 53 resection specimens and 9 biopsy specimens Giuseppe Zamboni, Jutta L�ttges, Paola Capelli et al. · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin 26 Oct 2004 668
47 Th2 and regulatory immune reactions are increased in immunoglobin G4-related sclerosing pancreatitis and cholangitis Yoh Zen, Takahiko Fujii, Kenichi Harada et al. · Hepatology Open access 24 May 2007 653
48 International, evidence-based consensus diagnostic criteria for HHV-8–negative/idiopathic multicentric Castleman disease David C. Fajgenbaum et al. · Blood Open access 13 Jan 2017 641
49 ALK1 and p80 Expression and Chromosomal Rearrangements Involving 2p23 in Inflammatory Myofibroblastic Tumor Cheryl M. Coffin, Ankita Patel, Sherrie L. Perkins et al. · Modern Pathology Open access Jun 2001 638
50 Lymphoplasmacytic sclerosing pancreatitis with cholangitis: A variant of primary sclerosing cholangitis extensively involving pancreas Kenji Kawaguchi, Morio Koike, Koji Tsuruta et al. · Human Pathology Apr 1991 637

Citations are OpenAlex's own counts, from its 2026-09-23 snapshot, so the ranking can differ from Google Scholar or Web of Science. A paper is listed for a field when OpenAlex files it under one of the field's topics; retracted papers and papers whose citation count cannot be traced to citing works are left out, and a preprint and the article it became are shown once. Release dates are OpenAlex's: where a source gave only a month or a year, that is what is shown. How the lists are chosen.